RT
: FDA is alerting patients and health care professionals to several voluntary recalls of extended release (ER) metformin due to the possibility the medicines could contain NDMA above the acceptable intake limit. To learn more, visit:
sábado, 18 de julio de 2020
FDA Updates and Press Announcements on NDMA in Metformin | FDA
FDA Updates and Press Announcements on NDMA in Metformin | FDA
RT
: FDA is alerting patients and health care professionals to several voluntary recalls of extended release (ER) metformin due to the possibility the medicines could contain NDMA above the acceptable intake limit. To learn more, visit:
RT
: FDA is alerting patients and health care professionals to several voluntary recalls of extended release (ER) metformin due to the possibility the medicines could contain NDMA above the acceptable intake limit. To learn more, visit:
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario